| Assessing Brain Metabolism Using MRS With Deuterated Glucose (NCT06594315) | University of California, San Francisco | 2022-07-20 |
| A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. (NCT05355701) | Pfizer | 2022-07-05 |
| AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients (NCT05182905) | Nader Sanai | 2022-05-27 |
| Brain Tumor Intraoperative Ultrasound Database (NCT05062772) | Hospital del Rio Hortega | 2022-05-25 |
| Connectivity Alterations After Levetiracetam Application (NCT04425798) | Beijing Neurosurgical Institute | 2022-05-25 |
| The KetoGlioma (Ketogenic Glioma) Study (NCT05373381) | Tufts Medical Center | 2022-05-18 |
| Tumor Treating Fields for the Treatment of Brainstem Gliomas (NCT05310448) | Emory University | 2022-05-11 |
| Mapping Molecular Markers of Brain Tumour Activity Using MRI (NCT05140785) | King's College Hospital NHS Trust | 2022-05-01 |
| ZOOMit-fMRI Identifies Language Functional Cortex (NCT05188534) | Beijing Neurosurgical Institute | 2022-02-01 |
| Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery (NCT05028400) | Insel Gruppe AG, University Hospital Bern | 2022-02-01 |
| Pembrolizumab, Olaparib, and Temozolomide for People With Glioma (NCT05188508) | Memorial Sloan Kettering Cancer Center | 2022-01-14 |
| Glioma Brain Tumours - E12513 - SensiScreen Glioma (NCT04539431) | Ente Ospedaliero Cantonale, Bellinzona | 2022-01-07 |
| Connectome-guided Onco-functional Resection With Tractography-Extended Neuronavigation in Brain Tumor Surgery (NCT07717827) | ARNAS Civico Di Cristina Benfratelli Hospital | 2022-01-01 |
| Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases (NCT05459441) | Shanghai Pudong Hospital | 2022-01-01 |
| LIQUID BIOPSY IN Low-grade Glioma Patients (NCT05133154) | University Hospital, Montpellier | 2022-01-01 |
| Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep Learning (NCT04407039) | Tao Xin | 2021-12-30 |
| Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation With Imaging Data (ECoG) (NCT05875935) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2021-12-17 |
| Strategic Intervention on Preserving Language Function During Awake Craniotomy (NCT05143775) | Beijing Neurosurgical Institute | 2021-12-01 |
| Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma (NCT05061251) | University of Texas Southwestern Medical Center | 2021-12-01 |
| Strategic Intervention on Preserving Motor Function During Awake Craniotomy (NCT05143788) | Beijing Neurosurgical Institute | 2021-12-01 |
| 68Ga-P16-093 PET/CT Imaging in Glioma Patients (NCT05569434) | Peking Union Medical College Hospital | 2021-11-28 |
| The circTeloDIAG: Liquid Biopsy for Glioma Tumor (NCT04931732) | Hospices Civils de Lyon | 2021-11-04 |
| Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma (NCT05076513) | Nader Sanai | 2021-10-29 |
| Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma (NCT04543201) | University of Rochester | 2021-10-08 |
| Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors (NCT04056910) | Jason J. Luke, MD | 2021-09-20 |
| [18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy (NCT04870580) | University College, London | 2021-09-01 |
| Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma (NCT05045027) | Jonsson Comprehensive Cancer Center | 2021-09-01 |
| Metabolic Characterization of Space Occupying Lesions of the Brain (NCT04233788) | Insel Gruppe AG, University Hospital Bern | 2021-09-01 |
| Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma (NCT04902586) | Zhongnan Hospital | 2021-06-19 |
| Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models (NCT04970615) | Sümeyye Sezer | 2021-05-15 |
| Study of GC101 TIL in Brain Glioma (Soochow2) (NCT04943913) | Shanghai Juncell Therapeutics | 2021-05-06 |
| Histomolecular Profiles of Gliomas in Children and Adolescent/Young Adults (NCT04916015) | Centre Hospitalier Universitaire, Amiens | 2021-04-01 |
| Use of Non-invasive Optical Analysis in Neurosurgery (NCT04712214) | Imperial College London | 2021-03-28 |
| Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data (NCT04792437) | Yu Yao, MD | 2021-03-10 |
| LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) (NCT04699773) | University of Maryland, Baltimore | 2021-02-20 |
| Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma Invasion (NCT04953468) | Peking University Third Hospital | 2021-02-19 |
| 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases (NCT04752267) | University of Southern California | 2021-02-15 |
| Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma (NCT04309552) | Weill Medical College of Cornell University | 2021-02-01 |
| Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma (NCT03868943) | Wake Forest University Health Sciences | 2021-01-27 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. (NCT04388033) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-12-01 |
| Tessa Jowell BRAIN MATRIX - Platform Study (NCT04274283) | University of Birmingham | 2020-11-24 |
| Anlotinib to Malignant Brainstem Glioma (NCT04668508) | Zhejiang Cancer Hospital | 2020-11-24 |
| The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and Visualization of Targeted Molecules of Glioma (NCT04781764) | Huashan Hospital | 2020-11-09 |
| Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies (NCT06387979) | Mayo Clinic | 2020-10-26 |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations (NCT04521686) | Eli Lilly and Company | 2020-10-01 |
| Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy (NCT04186832) | M.D. Anderson Cancer Center | 2020-09-28 |
| NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors (NCT04550663) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-09-25 |
| Enhanced Detection in Glioma Excision (NCT04556929) | University of Oxford | 2020-09-21 |
| An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors (NCT04539574) | M.D. Anderson Cancer Center | 2020-09-04 |
| Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks (NCT04975139) | Washington University School of Medicine | 2020-09-02 |
| Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas (NCT04772456) | University of Maryland, Baltimore | 2020-08-11 |
| 18F-FET PET/CT in the Management of Glioma (NCT06563024) | Buddhist Tzu Chi General Hospital | 2020-08-01 |
| Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients (NCT04446416) | NaviFUS Corporation | 2020-07-21 |
| Infigratinib in Recurrent High-Grade Glioma Patients (NCT04424966) | Nader Sanai | 2020-07-21 |
| Post-operative Imaging in High Grade Glioma: is Management Influenced? (NCT04738110) | King's College Hospital NHS Trust | 2020-07-20 |
| LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients (NCT04391595) | Nader Sanai | 2020-07-11 |
| fMRI Reveal Functional Preservation in Glioma Peritumoral Edema (NCT07343492) | West China Hospital | 2020-05-01 |
| Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas (NCT03532295) | Washington University School of Medicine | 2020-04-20 |
| MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas (NCT04373720) | M.D. Anderson Cancer Center | 2020-03-20 |
| Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma (NCT04205357) | Haukeland University Hospital | 2020-03-01 |
| Radiogenomic and Prognosis Analysis in Glioma (NCT04122521) | Asan Medical Center | 2020-01-12 |
| LITT Followed by Hypofractionated RT for Recurrent Gliomas (NCT04181684) | University of Maryland, Baltimore | 2020-01-08 |
| Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) (NCT04222309) | Northwell Health | 2020-01-06 |
| Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions (NCT04047264) | Mayo Clinic | 2020-01-01 |
| Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors (NCT03991832) | University Health Network, Toronto | 2019-12-31 |
| Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors (NCT04185038) | Seattle Children's Hospital | 2019-12-11 |
| Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma (NCT04114370) | James Mountz | 2019-10-22 |
| Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy (NCT03952598) | National Cancer Institute (NCI) | 2019-10-16 |
| A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas (NCT03632317) | University of Michigan Rogel Cancer Center | 2019-10-01 |
| Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas. (NCT04461002) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2019-09-30 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies (NCT03941626) | Shenzhen BinDeBio Ltd. | 2019-09-01 |
| Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma (NCT04065776) | St. Jude Children's Research Hospital | 2019-08-28 |
| Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas (NCT04055688) | H. Lee Moffitt Cancer Center and Research Institute | 2019-08-15 |
| 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma (NCT04001257) | University Hospital, Brest | 2019-06-17 |
| Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma (NCT03971812) | Assistance Publique Hopitaux De Marseille | 2019-06-07 |
| Social Determinants of Health in Glioblastoma Population (NCT03900689) | Wake Forest University Health Sciences | 2019-05-22 |
| Memory Perception Assessment in Central/Non-central Nervous System Cancers (NCT03975959) | Institut du Cancer de Montpellier - Val d'Aurelle | 2019-05-10 |
| TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT (NCT03741244) | The Second Hospital of Hebei Medical University | 2019-05-06 |
| Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype (NCT03718767) | National Cancer Institute (NCI) | 2019-03-27 |
| Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption (NCT03551249) | InSightec | 2019-03-26 |
| EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors (NCT03638167) | Seattle Children's Hospital | 2019-03-19 |
| Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients (NCT03865355) | Novosibirsk State University | 2019-03-13 |
| A Study Utilizing Escitalopram in Glioma Patients (NCT03728673) | University of Nebraska | 2019-03-06 |
| 68Ga-citrate PET/MR Imaging for Glioma (NCT03335280) | Susan Chang | 2019-02-26 |
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis (NCT03436433) | Duke University | 2019-01-31 |
| Proton vs. Photon Radiotherapy for Patients With WHO Grade 2-3 Glioma (NCT07750457) | University Hospital, Essen | 2019-01-15 |
| Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma (NCT03027388) | National Cancer Institute (NCI) | 2019-01-09 |
| rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide (NCT03687957) | Washington University School of Medicine | 2019-01-04 |
| Revision of the EORTC QLQ-BN20 Questionnaire (NCT04689321) | Leiden University Medical Center | 2018-12-19 |
| Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI (NCT04097535) | Imperial College London | 2018-12-06 |
| Biomarker-based Algorithm for Diagnosis of Glioma (NCT04194593) | Hospices Civils de Lyon | 2018-12-01 |
| Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma (NCT03739372) | University of California, San Francisco | 2018-11-28 |
| Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment (NCT03706625) | Assistance Publique - Hôpitaux de Paris | 2018-11-20 |
| Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis (NCT04220424) | The First Affiliated Hospital of Zhengzhou University | 2018-11-01 |
| Multimodal Imaging of Hypoxia in Gliomas (NCT03716986) | University Hospital, Caen | 2018-11-01 |
| Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction (NCT03641391) | Huashan Hospital | 2018-09-01 |
| Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients (NCT03626896) | NaviFUS Corporation | 2018-08-17 |
| HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (NCT03500991) | Seattle Children's Hospital | 2018-07-26 |
| Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma (NCT03514069) | Case Comprehensive Cancer Center | 2018-06-05 |